Abstract Background Randomised controlled trials RCTs in the 1970s and early 1980s showed the polysaccharide serogroup A vaccine SgAV prevented serogroup A meningococcal meningitis SGAMM . Subsequent non RCTs suggested significant variations in the age specific duration of protection among children. Objectives